thymic-factor--circulating and Hepatitis-B

thymic-factor--circulating has been researched along with Hepatitis-B* in 5 studies

Other Studies

5 other study(ies) available for thymic-factor--circulating and Hepatitis-B

ArticleYear
[Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Sovetskaia meditsina, 1990, Issue:6

    Topics: Adjuvants, Immunologic; Chronic Disease; Drug Evaluation; Hepatitis; Hepatitis B; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Peptides; Thymus Extracts; Thymus Hormones

1990
[Clinical characteristics of chronic hepatitis B in children and the principles of its staged treatment].
    Pediatriia, 1987, Issue:3

    Topics: Adjuvants, Immunologic; Child; Chronic Disease; Genetic Carrier Screening; Hepatitis B; Hepatitis, Chronic; Homozygote; Humans; Levamisole; Thymus Hormones

1987
[Dynamics of immunological indices in patients with chronic viral hepatitis B and the effect of thymalin therapy].
    Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1986, Issue:8

    The work deals with the results of the study of T-lymphocytes and their subpopulations (active, thermostable, theophylline-sensitive and theophylline-resistant) in 102 children with chronic viral hepatitis B, depending on the effectiveness of thymalin therapy. The sensitization of lymphocytes to specific antigens was studied. Among patients with chronic viral hepatitis B and cirrhosis of the liver the homozygous phenotype of haptoglobin is registered essentially more frequently (63.6% and 82.4% respectively) than among healthy persons (44.0%). The patients of this group showed a decrease in the number of T-lymphocytes, disturbances in the suppressor/helper ratio: hypersuppression in persisting hepatitis and hyposuppression in active hepatitis. In 71.6% of cases thymalin therapy produced an effect manifested by clinico-biochemical remission, an increase in the number of T-lymphocytes, thermostable cells and the normalization of the T-suppressor/T-helper ratio. In these patients sensitization to HBsAg essentially decreased (from 30.5% to 13.9%), while sensitization to human liver lipoprotein retained its high level even after treatment with thymalin.

    Topics: Adjuvants, Immunologic; Adolescent; Child; Child, Preschool; Chronic Disease; Haptoglobins; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunologic Deficiency Syndromes; Phenotype; T-Lymphocytes; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Thymus Hormones

1986
[Indications for using thymalin in the therapy of children with chronic viral hepatitis B].
    Voenno-meditsinskii zhurnal, 1986, Issue:3

    Topics: Adjuvants, Immunologic; Child; Chronic Disease; Drug Evaluation; Female; Hepatitis B; Humans; Male; T-Lymphocytes; Thymus Hormones

1986
[Changes in the cellular reactions in children with chronic hepatitis B, and the use of immunoregulatory drugs].
    Pediatriia, 1984, Issue:8

    Topics: Adjuvants, Immunologic; Child; Child, Preschool; Chronic Disease; Hepatitis B; Humans; Leukocyte Count; Lymphopenia; T-Lymphocytes; Thymus Hormones

1984